Vitabolizer
Vitabolizer, licence 80039723: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Loss For Her, Vitabolic Formula, Vitacuts
- Licence holder
- Vitaminol Inc.
- NPN or DIN-HM
- 80039723
- Status
- Inactive licence
- Licence date
- 11 February 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Cholécalciférol | 0.267 microgrammes | Not calculated |
| Papaïne Source : Papain | 20000.0 FCC PU | Not calculated |
| Papaïne Source : Carica papaya, fruit | 20000.0 FCC PU | Not calculated |
| Fer Source : Gluconate ferreux | 0.467 milligramme | 1,401 µg |
| Camellia sinensis Source : Feuille Extraction ratio : 1:1 Dry plant equivalent : 50 mg Potency : 25.0 mg caffeine | 50.0 mg | Not calculated |
| Papaïne Source : Papain | 10.0 milligramme | Not calculated |
| Papaïne Source : Carica papaya, fruit | 10.0 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Acide inosinique, Graine d'Anis vert, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. Helps the body to metabolize carbohydrates, fats, and proteins. Helps normal growth and development. Helps to form red blood cells and helps in their proper function. Papain is a digestive enzyme. Source of essential fatty acids for the maintenance of good health. Source of omega-6 fatty acids for the maintenance of good health. Source of linoleic acid for the maintenance of good health. To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heartbeat and/or difficulty breathing.
- Précautions et mises en garde
Keep out of reach of children. There is enough drug in this package to seriously harm a child. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach, and tomato). Consult health care practitioner prior to use if you have gastrointestinal lesions/ulcers, are taking anticoagulant agents, anti-inflammatory agents or other enzyme products or are having surgery. Consult a health care practitioner prior to use if you have a liver disorder or develop symptoms of liver trouble (such as abdominal pain, dark urine or jaundice). Consult a health care practitioner prior to use if you have an iron deficiency.
Source
Official Health Canada record, licence 80039723
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.